An observational study in Esophageal Atresia, sponsored by University Hospital, Lille. Completed at 37 sites in 3 countries. Open to participants aged Up to 1 Year. Per ClinicalTrials.gov, last updated 2026-05-05.
Sponsored by University Hospital, Lille · Observational
The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (tracheoesophageal fistula), sometimes associated (from 50%) of other malformations (heart, kidney, digestive ...).
The current prognosis for this ailment is good. However he persists a mortality (\<10%) and significant morbidity, firstly related malformations (heart, kidney, for example), and secondly with particularly difficult anatomical forms (Forms long defect) .
The prevalence of this condition is estimated to be 1/2500 in 3000 live births, making an estimated ± 2,500 new cases over to 10 years in France.
The current project aims to set up a national registry (Metropolitan France and Dom Tom) to measure the prevalence of esophageal atresia among live births, phenotypic characteristics, the circumstances of their diagnosis, and their initial future at short-term during the first year of life, at which time occurs the vast majority of deaths and complications in this disease.
37 studies on the registry are indexed under Esophageal Atresia; 12 are open to participants now.
This study's enrollment of 1,460 is above the median of 50 across 19 observational studies indexed under Esophageal Atresia.
Browse Esophageal Atresia studies →University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All living newborns having a esophageal atresia supported in a neonatal unit, neonatal intensive care and pediatric surgery of France
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: data collection
Number of esophageal atresia
Time frame: 10 years
Data collection patient with esophageal atresia
Circumstances of diagnosis, modalities of follow-up and clinical management
Time frame: 10 years
Total number of patients with complications
Time frame: 10 years
Death
Time frame: 10 years
Plan to share: No
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.